HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ho Jeong Kwon Selected Research

voacangine

1/2020Identification and Validation of VEGFR2 Kinase as a Target of Voacangine by a Systematic Combination of DARTS and MSI.
1/2012A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ho Jeong Kwon Research Topics

Disease

48Neoplasms (Cancer)
02/2024 - 01/2002
16Hypoxia (Hypoxemia)
01/2017 - 01/2002
9Melanoma (Melanoma, Malignant)
02/2024 - 09/2015
8Carcinogenesis
01/2015 - 01/2003
6Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 02/2003
6Fibrosarcoma
02/2011 - 03/2004
5Neoplasm Metastasis (Metastasis)
01/2020 - 11/2005
4Breast Neoplasms (Breast Cancer)
01/2023 - 02/2011
4Lymphoma (Lymphomas)
01/2019 - 11/2005
3Disease Progression
06/2020 - 09/2015
3Glioblastoma (Glioblastoma Multiforme)
01/2020 - 05/2015
3Colonic Neoplasms (Colon Cancer)
04/2009 - 02/2003
3Inflammation (Inflammations)
09/2008 - 07/2005
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2023 - 11/2014
2Hepatocellular Carcinoma (Hepatoma)
11/2023 - 08/2009
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 09/2020
2Obesity
12/2018 - 01/2014
2Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2018 - 11/2017
2Choroidal Neovascularization
03/2009 - 03/2008
2Corneal Neovascularization
12/2007 - 02/2007
2Carcinoma (Carcinomatosis)
11/2005 - 02/2003
1Fibrosis (Cirrhosis)
12/2023
1Adenocarcinoma
07/2023
1Triple Negative Breast Neoplasms
01/2023
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2022
1Tauopathies
10/2021
1Atherosclerotic Plaque (Atheroma)
12/2020
1Adenocarcinoma of Lung
06/2020
1Glioma (Gliomas)
02/2020

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
02/2024 - 12/2007
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 11/2002
10Histone Deacetylase InhibitorsIBA
01/2015 - 01/2002
10Histone Deacetylases (Histone Deacetylase)IBA
11/2014 - 01/2003
8Biomarkers (Surrogate Marker)IBA
04/2022 - 12/2010
7Carrier Proteins (Binding Protein)IBA
12/2022 - 02/2011
7Reactive Oxygen Species (Oxygen Radicals)IBA
10/2016 - 09/2008
6Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
04/2022 - 04/2010
5Angiogenesis InhibitorsIBA
09/2015 - 01/2002
4ProteomeIBA
01/2021 - 02/2012
4Messenger RNA (mRNA)IBA
06/2020 - 10/2005
4NF-kappa B (NF-kB)IBA
01/2010 - 07/2005
3Phosphotransferases (Kinase)IBA
12/2022 - 09/2020
3CholesterolIBA
12/2020 - 11/2017
3DNA (Deoxyribonucleic Acid)IBA
12/2019 - 11/2002
3Oxygen (Dioxygen)IBA
01/2019 - 03/2009
3CurcuminIBA
01/2017 - 08/2003
3EnzymesIBA
02/2013 - 01/2003
3VorinostatFDA Link
02/2011 - 10/2008
3Calmodulin (Calcium-Dependent Activator Protein)IBA
08/2010 - 10/2004
3trichostatin A (A 300)IBA
11/2005 - 02/2003
3theasinensin AIBA
11/2005 - 02/2003
2DaptomycinFDA Link
10/2021 - 01/2016
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 09/2020
2voacangineIBA
01/2020 - 01/2012
2LipidsIBA
12/2018 - 11/2005
2LDL Lipoproteins (beta Lipoproteins)IBA
11/2017 - 11/2005
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2017 - 09/2015
2Histones (Histone)IBA
01/2015 - 11/2005
2terpestacinIBA
09/2013 - 04/2010
2ZincIBA
02/2013 - 08/2003
2CarcinogensIBA
03/2012 - 02/2012
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2007 - 08/2003
2Syndecan-2IBA
11/2005 - 02/2003
2Complementary DNA (cDNA)IBA
10/2005 - 02/2003
2CD13 Antigens (Alanine Aminopeptidase)IBA
01/2004 - 08/2003
1DiketopiperazinesIBA
12/2023
1Histidine (L-Histidine)FDA Link
12/2023
1DipeptidesIBA
12/2023
1ChloridesIBA
12/2023
1Proline (L-Proline)FDA Link
12/2023
1epidermal growth factor receptor VIIIIBA
11/2023
1ertredinIBA
11/2023
1Anaplastic Lymphoma KinaseIBA
07/2023
1MucinsIBA
07/2023
1Molecular Chaperones (Chaperone, Molecular)IBA
01/2023
1ipomoeassin FIBA
01/2023
1Dasatinib (BMS 354825)FDA Link
12/2022
1ribosomal protein S19IBA
10/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2021
1tau Proteins (tau Protein)IBA
10/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1ParaffinIBA
01/2021
1Apolipoproteins E (ApoE)IBA
12/2020
1ApolipoproteinsIBA
12/2020
1Growth Factor ReceptorsIBA
09/2020
1DNA Polymerase I (Klenow Fragment)IBA
09/2020
1Antineoplastic Agents (Antineoplastics)IBA
02/2020
1Temozolomide (Temodar)FDA LinkGeneric
02/2020
1Immunologic Factors (Immunomodulators)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Acid CeramidaseIBA
03/2019
1CeramidesIBA
03/2019
1HalogensIBA
01/2019
1trametinibIBA
01/2019

Therapy/Procedure

17Therapeutics
02/2024 - 01/2002
2Lasers (Laser)
01/2021 - 03/2009
1Immunotherapy
01/2021